Cancer Immunotherapy: The way to the Nobel Prize in Medicine

  • Nima Rezaei Research Center for Immunodeficiencies, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran. AND Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran. and Cancer Immunology Project (CIP), Universal Scientific Education and Research Network (USERN), Tehran, Iran
  • Elham Rayzan Research Center for Immunodeficiencies, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran. and International Hematology/Oncology of Pediatrics Experts (IHOPE), Universal Scientific Education and Research Network (USERN), Tehran, Iran.
Keywords: No keywords ###

Abstract

Cancer Immunotherapy: The way to the Nobel Prize in Medicine

References

The Nobel Prize organisation. The Nobel Prize 2018. (Accessed October 2018, 1, at https://www.nobelprize.org/prizes/).

IREG. IREG Observatory on Academic Ranking and Excellence 2018. (Accessed October 2018, 1, at http://ireg-observatory.org/en/initiatives).

The Nobel Prize organisation. The Nobel Prize in Physiology or Medicine 2018. (Accessed October 2018, 1, at https://www.nobelprize.org/prizes/medicine/ 2018/summary/).

Hammerich L, Binder A, Brody JD. In situ vaccination: Cancer immunotherapy both personalized and off-the-shelf. Mol Oncol 2015;9:1966-81.

Alison JP. The University of Texas MD Anderson Cancer Center 2018. (Accessed October 2018, 1, at https://faculty.mdanderson.org/profiles/james_allison.html).

Hodi FS, O'Day SJ, McDermott DF, Weber RW, Sosman JA, Haanen JB, et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med 2010;363:711-23.

Ledford H, Else H, Warren M. Cancer immunologists scoop medicine Nobel prize. Nature 2018;562:20-1.

Topalian SL, Hodi FS, Brahmer JR, Gettinger SN, Smith DC, McDermott DF, et al. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N Engl J Med 2012;366:2443-54.

Larkin J, Hodi FS, Wolchok JD. Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma. N Engl J Med 2015;373:1270-1.

Sriratana P, Norton J. New Immunotherapies in Oncology Treatment and Their Side Effect Profiles. J Am Board Fam Med 2018;31:620-7.

Wills B, Brahmer JR, Naidoo J. Treatment of Complications from Immune Checkpoint Inhibition in Patients with Lung Cancer. Curr Treat Options Oncol 2018;19:46.

Honjo T. Biography 2018. (Accessed October 2018, 1, at http://www.wcp2018.org/program/bio/Tasuku_ Honjo.html).

Published
2019-01-12
How to Cite
1.
Rezaei N, Rayzan E. Cancer Immunotherapy: The way to the Nobel Prize in Medicine. Acta Med Iran. 56(10):623-624.
Section
Editorial